• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

稳健且资源高效的生产工艺,适用于通过高细胞密度种子扩增培养和优化感染策略大规模生产杆状病毒。

Robust and resource-efficient production process suitable for large-scale production of baculovirus through high cell density seed train and optimized infection strategy.

作者信息

Achleitner Lena, Winter Martina, Aguilar Patricia Pereira, Lingg Nico, Jungbauer Alois, Klausberger Miriam, Satzer Peter

机构信息

acib - Austrian Centre of Industrial Biotechnology, Muthgasse 11, 1190 Vienna, Austria; Institute of Bioprocess Science and Engineering, Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna (BOKU), Muthgasse 18, 1190 Vienna, Austria.

Institute of Molecular Biotechnology, Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna (BOKU), Muthgasse 18, 1190 Vienna, Austria.

出版信息

N Biotechnol. 2024 May 25;80:46-55. doi: 10.1016/j.nbt.2024.01.002. Epub 2024 Feb 1.

DOI:10.1016/j.nbt.2024.01.002
PMID:38302001
Abstract

The aim of this study was the development of a scalable production process for high titer (10 pfu/mL and above) recombinant baculovirus stocks with low cell line-derived impurities for the production of virus-like particles (VLP). To achieve this, we developed a high cell density (HCD) culture for low footprint cell proliferation, compared different infection strategies at multiplicity of infection (MOI) 0.05 and 0.005, different infection strategies and validated generally applicable harvest criteria of cell viability ≤ 80%. We also investigated online measurable parameters to observe the baculovirus production. The infection strategy employing a very low virus inoculum of MOI 0.005 and a 1:2 dilution with fresh medium one day after infection proved to be the most resource efficient. There, we achieved higher cell-specific titers and lower host cell protein concentrations at harvest than other tested infection strategies with the same MOI, while saving half of the virus stock for infecting the culture compared to other tested infection strategies. HCD culture by daily medium exchange was confirmed as suitable for seed train propagation, infection, and baculovirus production, equally efficient as the conventionally propagated seed train. Online measurable parameters for cell concentration and average cell diameter were found to be effective in monitoring the production process. The study concluded that a more efficient VLP production process in large scale can be achieved using this virus stock production strategy, which could also be extended to produce other proteins or extracellular vesicles with the baculovirus expression system.

摘要

本研究的目的是开发一种可扩展的生产工艺,用于生产高滴度(10 pfu/mL及以上)、细胞系衍生杂质低的重组杆状病毒储备液,以用于生产病毒样颗粒(VLP)。为实现这一目标,我们开发了一种高细胞密度(HCD)培养方法以实现低占地面积的细胞增殖,比较了感染复数(MOI)为0.05和0.005时的不同感染策略、不同感染策略,并验证了细胞活力≤80%这一普遍适用的收获标准。我们还研究了在线可测量参数以观察杆状病毒的生产情况。结果表明,采用MOI为0.005的极低病毒接种量并在感染后一天用新鲜培养基进行1:2稀释的感染策略最为节省资源。在此策略下,与相同MOI的其他测试感染策略相比,收获时我们获得了更高的细胞特异性滴度和更低的宿主细胞蛋白浓度,同时与其他测试感染策略相比,用于感染培养物的病毒储备液节省了一半。通过每日更换培养基进行的HCD培养被证实适用于种子批传代、感染和杆状病毒生产,与传统传代的种子批效率相当。发现细胞浓度和平均细胞直径的在线可测量参数可有效监测生产过程。该研究得出结论,使用这种病毒储备液生产策略可实现大规模更高效的VLP生产工艺,该策略还可扩展用于用杆状病毒表达系统生产其他蛋白质或细胞外囊泡。

相似文献

1
Robust and resource-efficient production process suitable for large-scale production of baculovirus through high cell density seed train and optimized infection strategy.稳健且资源高效的生产工艺,适用于通过高细胞密度种子扩增培养和优化感染策略大规模生产杆状病毒。
N Biotechnol. 2024 May 25;80:46-55. doi: 10.1016/j.nbt.2024.01.002. Epub 2024 Feb 1.
2
Sf9 Cell Metabolism Throughout the Recombinant Baculovirus and Rabies Virus-Like Particles Production in Two Culture Systems.在两种培养体系中,Sf9 细胞代谢贯穿于重组杆状病毒和狂犬病病毒样颗粒的生产过程中。
Mol Biotechnol. 2024 Feb;66(2):354-364. doi: 10.1007/s12033-023-00759-2. Epub 2023 May 10.
3
Baculovirus production for gene therapy: the role of cell density, multiplicity of infection and medium exchange.用于基因治疗的杆状病毒生产:细胞密度、感染复数和培养基更换的作用
Appl Microbiol Biotechnol. 2009 Jan;81(6):1041-9. doi: 10.1007/s00253-008-1727-4. Epub 2008 Oct 16.
4
Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor.使用杆状病毒/昆虫细胞悬浮培养系统生产重组腺相关病毒载体:从摇瓶到20升生物反应器。
Biotechnol Prog. 2005 Jan-Feb;21(1):154-60. doi: 10.1021/bp049802e.
5
Performance Comparison of Recombinant Baculovirus and Rabies Virus-like Particles production Using Two Culture Platforms.使用两种培养平台生产重组杆状病毒和狂犬病病毒样颗粒的性能比较
Vaccines (Basel). 2022 Dec 24;11(1):39. doi: 10.3390/vaccines11010039.
6
Scale-up of virus-like particles production: effects of sparging, agitation and bioreactor scale on cell growth, infection kinetics and productivity.病毒样颗粒生产的放大:鼓泡、搅拌和生物反应器规模对细胞生长、感染动力学和生产力的影响。
J Biotechnol. 2004 Jan 8;107(1):55-64. doi: 10.1016/j.jbiotec.2003.09.012.
7
Application of advanced quantification techniques in nanoparticle-based vaccine development with the Sf9 cell baculovirus expression system.高级定量技术在基于纳米颗粒的疫苗开发中的应用,该疫苗是利用 Sf9 细胞杆状病毒表达系统开发的。
Vaccine. 2020 Feb 11;38(7):1849-1859. doi: 10.1016/j.vaccine.2019.11.087. Epub 2020 Jan 5.
8
Sf9 Cells Metabolism and Viability When Coinfected with Two Monocistronic Baculoviruses to Produce Rabies Virus-like Particles.Sf9 细胞在同时感染两种单顺反子杆状病毒时的代谢和活力,以生产狂犬病病毒样颗粒。
Mol Biotechnol. 2023 Jun;65(6):970-982. doi: 10.1007/s12033-022-00586-x. Epub 2022 Nov 18.
9
Optimization of chimeric HIV-1 virus-like particle production in a baculovirus-insect cell expression system.杆状病毒-昆虫细胞表达系统中嵌合HIV-1病毒样颗粒生产的优化
Biotechnol Prog. 2009 Jul-Aug;25(4):1153-60. doi: 10.1002/btpr.187.
10
Modeling rotavirus-like particles production in a baculovirus expression vector system: Infection kinetics, baculovirus DNA replication, mRNA synthesis and protein production.杆状病毒表达载体系统中轮状病毒样颗粒产生的建模:感染动力学、杆状病毒DNA复制、mRNA合成及蛋白质产生
J Biotechnol. 2007 Mar 10;128(4):875-94. doi: 10.1016/j.jbiotec.2007.01.003. Epub 2007 Jan 10.

引用本文的文献

1
Multiplicity of infection and culture medium on the SARS-CoV-2 virus like-particles production by baculovirus/insect system.杆状病毒/昆虫系统产生严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒样颗粒时的感染复数及培养基的影响
Biotechnol Lett. 2025 Mar 6;47(2):32. doi: 10.1007/s10529-025-03572-w.